GCG and dilated cardiomyopathy: Administration of GLP-1(9–36) in dog model with dilated cardiomyopathy preserved LV function and increased glucose uptake, indicating that GLP-1(9–36) is a biologically active metabolite which is independent of GLP-1R pathway (Nikolaidis et al., 2005).